Skip to main content

Peer Review reports

From: Risk factors for pneumonitis in advanced extrapulmonary cancer patients treated with immune checkpoint inhibitors

Original Submission
11 Sep 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
23 Oct 2021 Reviewed Reviewer Report
24 Oct 2021 Reviewed Reviewer Report
5 Nov 2021 Reviewed Reviewer Report
7 Nov 2021 Reviewed Reviewer Report
23 Nov 2021 Author responded Author comments - Yasuki Uchida
Resubmission - Version 3
23 Nov 2021 Submitted Manuscript version 3
3 Dec 2021 Author responded Author comments - Yasuki Uchida
Resubmission - Version 4
3 Dec 2021 Submitted Manuscript version 4
13 Dec 2021 Reviewed Reviewer Report
14 Dec 2021 Reviewed Reviewer Report
21 Dec 2021 Reviewed Reviewer Report
14 Feb 2022 Author responded Author comments - Yasuki Uchida
Resubmission - Version 5
14 Feb 2022 Submitted Manuscript version 5
20 Feb 2022 Reviewed Reviewer Report
29 Mar 2022 Author responded Author comments - Yasuki Uchida
Resubmission - Version 6
29 Mar 2022 Submitted Manuscript version 6
4 Apr 2022 Reviewed Reviewer Report
14 Apr 2022 Author responded Author comments - Yasuki Uchida
Resubmission - Version 7
14 Apr 2022 Submitted Manuscript version 7
18 Apr 2022 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
5 May 2022 Editorially accepted
16 May 2022 Article published 10.1186/s12885-022-09642-w

You can find further information about peer review here.

Back to article page